Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Measles, mumps, and rubella virus vaccine (M-M-R™II): a review of 32 years of clinical and postmarketing experience.

Lievano F, Galea SA, Thornton M, Wiedmann RT, Manoff SB, Tran TN, Amin MA, Seminack MM, Vagie KA, Dana A, Plotkin SA.

Vaccine. 2012 Nov 6;30(48):6918-26. doi: 10.1016/j.vaccine.2012.08.057. Review.

PMID:
22959986
2.

The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.

Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K.

N Engl J Med. 1994 Nov 24;331(21):1397-402.

3.

Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children.

Feiterna-Sperling C, Brönnimann R, Tischer A, Stettler P, Durrer P, Gaedicke G.

Pediatr Infect Dis J. 2005 Dec;24(12):1083-8.

PMID:
16371870
4.

Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines.

Schwarzer S, Reibel S, Lang AB, Struck MM, Finkel B, Gerike E, Tischer A, Gassner M, Glück R, Stück B, Cryz SJ Jr.

Vaccine. 1998 Jan-Feb;16(2-3):298-304.

PMID:
9607046
5.

MMR vaccination and disease elimination: the Finnish experience.

Davidkin I, Kontio M, Paunio M, Peltola H.

Expert Rev Vaccines. 2010 Sep;9(9):1045-53. doi: 10.1586/erv.10.99. Review.

PMID:
20822347
6.

Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.

Böttiger M, Christenson B, Strandell A, Romanus V.

Dev Biol Stand. 1986;65:37-43.

PMID:
3556776
7.
8.
10.

A new combination vaccine for measles, mumps, rubella and varicella.

Zareba G.

Drugs Today (Barc). 2006 May;42(5):321-9. Review.

PMID:
16801995
12.

Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.

Nolan T, McIntyre P, Roberton D, Descamps D.

Vaccine. 2002 Dec 13;21(3-4):281-9.

PMID:
12450703
13.

Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella.

Nascimento Silva JR, Camacho LA, Siqueira MM, Freire Mde S, Castro YP, Maia Mde L, Yamamura AM, Martins RM, Leal Mde L; Collaborative Group for the Study of Yellow Fever Vaccines..

Vaccine. 2011 Aug 26;29(37):6327-34. doi: 10.1016/j.vaccine.2011.05.019.

14.

Two doses of MMR vaccine--sufficient to eradicate measles, mumps and rubella?

Fahlgren K.

Scand J Soc Med. 1988;16(3):129-35. Review.

PMID:
3057621
15.

Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.

Nolan T, Bernstein DI, Block SL, Hilty M, Keyserling HL, Marchant C, Marshall H, Richmond P, Yogev R, Cordova J, Cho I, Mendelman PM; LAIV Study Group..

Pediatrics. 2008 Mar;121(3):508-16. doi: 10.1542/peds.2007-1064.

PMID:
18310199
16.

The immunogenicity and reactogenicity of the trivalent vaccine, Trimovax, indicated for prevention of measles, mumps, and rubella, in 12-month-old children in Belarus.

Samoilovich EO, Kapustik LA, Feldman EV, Yermolovich MA, Svirchevskaya AJ, Zakharenko DF, Fletcher MA, Titov LP.

Cent Eur J Public Health. 2000 Aug;8(3):160-3.

PMID:
10965439
17.

A combination vaccine against measles, mumps, rubella and varicella.

Knuf M, Faber J, Barth I, Habermehl P.

Drugs Today (Barc). 2008 Apr;44(4):279-92. Review.

PMID:
18536786
18.

Pediatric sentinel surveillance of vaccine-preventable diseases in Italy.

Ciofi Degli Atti ML, Salmaso S, Bella A, Arigliani R, Gangemi M, Chiamenti G, Brusoni G, Tozzi AE; Pediatric Sentinel Surveillance Study Group..

Pediatr Infect Dis J. 2002 Aug;21(8):763-8.

PMID:
12192166
19.
20.

Measles-mumps-rubella vaccine in the Italian armed forces.

D'Amelio R, Biselli R, Fascia G, Natalicchio S.

JAMA. 2000 Oct 25;284(16):2059. No abstract available.

PMID:
11042753
Items per page

Supplemental Content

Support Center